RTHM

RTHM is a secure health platform that makes it easy to gather your records, connect the dots with AI, and affordably access treatments.

01/15/2026

A recent study shows that blood from people with ME/CFS and Long COVID can directly damage healthy human muscle tissue. When healthy muscle was exposed topatient blood, it became weaker, showed signs of energy stress in the mitochondria, and began to break down over time.

Researchers used bioengineered muscle to study the effects of blood alone, without factors like inactivity or deconditioning. Muscle problems appeared within 48 hours and became worse with longer exposure. This suggests the damage happens in stages, starting with short-term stress and leading to weakness and breakdown.

These findings challenge the idea that symptoms are caused by deconditioning and instead point to harmful factors in the blood. The study also introduces a new lab model that closely matches patient symptoms and could speed up research on tests and treatments.

👉 Read the full study: https://doi.org/10.1088/1758-5090/adf66c

01/14/2026

In a recent episode of The POTScast, Dr. Jennifer Curtin, co-founder and Chief Medical Officer at RTHM, joined host Jill Brook to talk about RTHM’s new HIPAA-compliant AI platform, designed to empower complex patients with actionable insights and resources, no matter how long they’ve been sick.

Listen as Jill Brook shares her experience using RTHM’s platform, and how it’s been a game changer for her.

🎙️Listen now—link in bio!

https://www.standinguptopots.org/potscast/new-free-ai-intelligence-platform-for-patients-with-dr-jen-curtin/

Help keep conversations like this going: standinguptopots.org/donate

12/31/2025

You’re invited: Special Caregiver Wellness Workshop this Sunday

At the next Caregiver Wisdom monthly support group for chronic illness caregivers, we’ll be doing something a little special — a workshop on assessing your holistic well-being using the Wellness Wheel.

🗓 Sunday, January 4
⏰ 12–1:30 p.m. PST / 3–4:30 p.m. EST / 7–8:30 p.m. GMT

Caregiving so often pushes our needs to the bottom of the list. This gathering is a chance to pause, check in, and ask yourself: What do I need right now?

Together, we’ll explore the eight interconnected areas of wellness through a compassionate lens and identify small, doable habits that can support your resilience and create moments of joy — even in the midst of caregiving.

We’ll also have time for small breakout groups, a part of these meetings many caregivers value for deeper connection.

This group centers the experiences of caregivers of loved ones with ME/CFS, Long COVID, and related illnesses, while warmly welcoming all caregivers.

If you’re longing for reflection, connection, or simply a place to exhale, this space is for you.

📩 Email me at kim@caregiverwisdom.net or DM me if you’d like to join us. We'd love to see you.

12/29/2025

What is the RTHM Ecosystem?

In this clip, Dr. Jennifer Curtin, RTHM co-founder and Chief Medical Officer, explains how the RTHM is structured today. RTHM’s new HIPAA-compliant intelligence platform offers access to personalized evidence-supported insights on your case and is the new home for RTHM Direct’s treatment options, all in one platform.

The RTHM Clinic remains a separate, more comprehensive telehealth care pathway that treats patients in the following states: AZ, CA, CO, FL, NY, NC, OR, TN, TX, VA, and WA. More states are coming soon!

This ecosystem represents RTHM’s vision for expanding access to informed care and support for people with Long COVID, ME/CFS, POTS, EDS and more.

Learn more at https://www.rthm.com/about-us.

12/23/2025

The early months are overwhelming, scary, and unclear. What you need most is a way to understand what’s happening in your body and what to do next.

That’s where RTHM comes in. Our new intelligence platform gives you that clarity by gathering all your health data in one secure place and using a HIPAA-compliant AI chat informed by your health information to guide you.

RTHM’s intelligence platform helps you understand your symptoms, uncover conditions that may have been triggered by COVID (ME/CFS, POTS, MCAS, etc.), and learn what testing may make sense to pursue next. The platform can also help you prepare for your next clinician visit (including how to ask your clinician about testing and diagnoses suggested by the platform). Use it to understand lab test results, explore treatment, lifestyle, and testing options, review key research, draft support letters, and more.

When your full health picture is finally visible in one place, the next steps become much clearer and less overwhelming.

Learn more about how RTHM’s intelligence platform is changing what’s possible for people with Long COVID and other IACCs.

https://www.rthm.com/

12/22/2025

Stay ahead of winter viruses this year and have what you need on hand ahead of time! Take a little time now to prepare so you aren’t scrambling to get what you need while sick, stressed or overwhelmed by holiday plans.

The RTHM COVID-19 Preparedness Kit brings together clinician informed guidance on supplements, medications, and early support strategies commonly used in care for COVID-19 and infection-associated chronic conditions. Each suggestion is grounded in available research and clinical experience.

Swipe to see what is in the kit or read more information on how to be prepared this season here: https://www.rthm.com/resources/blogs/youve-got-covid-minimize-your-symptoms-and-reduce-your-long-covid-risk

12/18/2025

The RTHM team had an inspiring time at Mayo Clinic’s VIBE Summit, where innovators, clinicians, and researchers gathered to explore how innovation, AI, and intelligent automation can transform patient care.

At the summit, co-founders Dr. Jennifer Curtin and Dr. Ryan Kellogg met with key people across the ecosystem offering a demo of RTHM’s tools to support bringing personalized and effective care to patients with infection-associated chronic conditions at scale. As a participating company in the Mayo Clinic Platform_Accelerate program, RTHM is already working with Mayo’s large, de-identified clinical dataset to see if they can predict the most effective next tests and treatments for people with IACCs — helping get people to the right diagnosis and treatments, faster.

12/16/2025

Not all research is created equal.

In this clip, Dr. Jennifer Curtin, RTHM Co-founder and Chief Medical Officer, explains why AI must be built on the right evidence to truly support people living with complex chronic illness.

Several clinical AI tools still surface outdated or incorrect guidance for ME/CFS. RTHM’s intelligence platform is different. The platform prioritizes carefully curated research that reflects current guidance and excludes notoriously flawed research (i.e. around GET and CBT for ME/CFS) in the IACC space.

RTHM’s HIPAA-compliant intelligence platform securely brings all your health data into one place and uses research-supported, IACC-informed AI to surface patterns, explain findings, and support you in identifying your next steps. For many people, this is the first time their case feels clearly organized in one place, actionable, and truly understood.

Learn more at rthm.com.

12/10/2025

A major new RECOVER Initiative study analyzing 6.4 million electronic health records from 2020–2024 reveals a critical pattern: the risk of Long COVID has remained stable across the entire pandemic.

Using multiple definitions of Long COVID, researchers found consistent incidence rates in both adults and children, with no meaningful decline even through three Omicron waves. Peaks aligned with new variants, but overall risk did not fall, indicating that Long COVID continues to pose a persistent public health challenge.

The findings reinforce that Long COVID is not diminishing over time and require continued and renewed attention, prevention, and support for those affected.

Stay informed on the latest IACC research and sign up for our email list through the link in our bio.

👉 Read the full study: https://doi.org/10.1093/cid/ciaf046

12/05/2025

People living with Long Covid and other IACCs need clarity and support.

Maya, a nurse who has been bedridden for four years, shares how RTHM’s intelligence platform helped her understand complex imaging results, identify next steps, and see her full health picture without spending weeks gathering information on her own.

RTHM’s HIPAA-compliant intelligence platform securely brings all your health data into one place and uses research-grounded, IACC-informed AI to surface patterns, explain findings, and support decision-making. For many patients, this is the first time their case feels clearly organized in one place, actionable, and truly understood.

It’s not just AI. It’s AI designed for people living with ME/CFS, Long COVID, POTS, MCAS, EDS, and other IACCs.

Learn more about RTHM’s intelligence platform here: rthm.com

12/01/2025

Many people still don’t know that metformin, a medication used safely for decades to treat diabetes, may help lower the risk of Long COVID when taken early during acute COVID.

In a recent article, “Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?” by The Sick Times, Dr. Jennifer Curtin explained why she uses metformin during acute COVID for her Long COVID patients.

“We generally use metformin during acute COVID reinfections for patients, just to try and reduce any potential worsening.”

The COVID-OUT phase 3 trial found that people treated with metformin during an active SARS-CoV-2 infection were ~41% less likely to develop Long COVID vs. placebo.

Read the full story at The Sick Times: https://ow.ly/iTrC50XAl5C

11/25/2025

A recent study shows that an AI tool called BioMapAI can identify people with ME/CFS with 90% accuracy by analyzing stool, blood, and other routine lab data.

Developed by researchers at the Jackson Laboratory and Duke University School of Medicine, BioMapAI integrated multi-omics data from 153 ME/CFS patients and 96 controls, revealing how disruptions across the microbiome, immune system, and metabolism are linked to fatigue, pain, sleep, and emotional symptoms.

The study underscores that ME/CFS may not have a single biomarker but rather a network of systems out of balance, requiring multiple interventions to restore health.

Stay informed on the latest IACC research and sign up for our email list through the link in our bio.

👉 Learn how AI is helping map complex disease biology. Read the full study: https://doi.org/10.1038/s41591-025-03788-3

Address

2261 Market Street #10535
San Francisco, CA
94114

Website

https://www.rthm.com/, https://linktr.ee/rthm_health, https://www.direct.rthm.com/intelligence?utm_source=fb&utm_medium=

Alerts

Be the first to know and let us send you an email when RTHM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RTHM:

Shortcuts

Want your practice to be the top-listed Clinic in San Francisco?